Patent details

EP2318015 Title: TREATMENT OF CANCERS OF THE BLOOD USING SELECTED GLYCOMIMETIC COMPOUNDS

Basic Information

Publication number:
EP2318015
PCT Application Number:
PCT/US/2009/046906
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097635353
PCT Publication Number:
WO/2009/152245
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF CANCERS OF THE BLOOD USING SELECTED GLYCOMIMETIC COMPOUNDS
French Title of Invention:
TRAITEMENT DE CANCERS DU SANG À L AIDE DE COMPOSÉS GLYCOMIMÉTIQUES CHOISIS
German Title of Invention:
BEHANDLUNG VON BLUTKREBS MIT AUSGEWÄHLTEN GLYKOMIMETISCHEN VERBINDUNGEN
SPC Number:

Dates

Filing date:
10/06/2009
Grant date:
07/08/2013
EP Publication Date:
07/08/2013
PCT Publication Date:
17/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/05/2011
EP B1 Publication Date:
07/08/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/06/2014
Expiration date:
10/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/06/2009
 
 

Name:
GlycoMimetics Inc.
Address:
401 Professional Drive Suite 250, Gaithersburg, MD 20879, United States (US)

Inventor

1

Name:
PATTON John, T., Jr.
Address:
United States (US)

2

Name:
MAGNANI John, L.
Address:
United States (US)

3

Name:
SMITH Theodore, A.G.
Address:
United States (US)

Priority

1

Priority Number:
131969 P
Priority Date:
13/06/2008
Priority Country:
United States (US)

2

Priority Number:
99270 P
Priority Date:
23/09/2008
Priority Country:
United States (US)

3

Priority Number:
172853 P
Priority Date:
27/04/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/7072;
Filing date Document type Number of pages